|
Market Closed -
Nasdaq
04:00:00 2026-10-23 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.5193 USD | -7.84% |
|
+6.37% | -67.13% |
| Oct. 11 | Certain Common Stock of Outlook Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2026. | CI |
| Oct. 09 | Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OTLK | Delayed | |
CBOE
| OTLK | Real-time | |
|
Tradegate
| 41O | Real-time | |
|
Börse Stuttgart
| 41O | Delayed | |
|
Deutsche Boerse AG
| 41O | Delayed | |
|
Boerse Muenchen
| 41O | Real-time | |
|
Xetra
| 41O | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 0.5735 | 1.83 | 2.05 |
| Spread/Res. | -9.45% | -71.62% | -74.67% |
| Spread/Supp. | +10.44% | +140.75% | +149.54% |
| Support | 0.4702 | 0.2157 | 0.2081 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- OTLK Stock
- Charts Outlook Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
